Clinical Trials Browser

Phase 2 × Nausea × 1 year × Clear all

NCT07169851 2026-03-06

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Phase 2 Recruiting

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT00489307 2025-11-12

Dexamethasone for Symptom Burden in Advanced Cancer Patients

Phase 2 Active not recruiting

132 enrolled 15 charts

Anorexia, Fatigue, Nausea, Pain

NCT03118986 2025-10-08

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Phase 2 Recruiting

Nausea, Neoplasms, Vomiting

NCT03948074 2025-09-10

CAFCARS

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Phase 2 Completed

43 enrolled 23 charts

GastrointestinalOtherPlasma cell

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

NCT06904235 2025-07-28

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Phase 2 Recruiting

Nausea, Vomiting